Evidence map›Paper›PMID 27289369›Full record

ArticleAIDS and behavior2016

Assessing Adherence to Antiretroviral Therapy in a Rural Paediatric Cohort in KwaZulu-Natal, South Africa.

Chanelle Smith, Tanuja N Gengiah, Nonhlanhla Yende-Zuma, Michele Upfold, Kogieleum Naidoo

Abstract read
In one paragraph

Article in AIDS and behavior, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chanelle SmithCAPRISA-Centre for the AIDS Programme of Research in South Africa, Durban, South Africa. Chanelle.smith@lifehealthcare.co.za.
Tanuja N GengiahCAPRISA-Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
Nonhlanhla Yende-ZumaCAPRISA-Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
Michele UpfoldCAPRISA-Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
Kogieleum NaidooCAPRISA-Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.

Funding

CAPRISA AIDS TREATMENT PROGRAMMEU2GPS001350 · PS · UNIVERSITY OF KWAZULU-NATAL · PI ABDOOL KARIM, SALIM S · 2008 to 2013
$30.7M
University of KwaZulu-Natal - CAPRISA HIV/AIDS Clinical Trials UnitU01AI069469 · NIAID · UNIVERSITY OF KWAZULU-NATAL · PI ABDOOL KARIM, SALIM S · 2007 to 2011
$28.0M
The Viral Set Point in HIV-1 Subtype C InfectionU19AI051794 · NIAID · UNIVERSITY OF KWAZULU-NATAL · PI ABDOOL KARIM, SALIM S · 2002 to 2007
$22.5M
TUBERCULOSIS SUPPLEMENTD43TW000231 · FIC · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI ABDOOL KARIM, QUARRAISHA · 1993 to 2014
$13.1M
FIC NIH HHS D43 TW000231NCHHSTP CDC HHS U2G PS001350NIAID NIH HHS U01 AI069469NIAID NIH HHS U19 AI051794PEPFAR
6 · The paper itself

Abstract

Achieving optimal adherence to ARV's in a rural paediatric population is challenging. Monitoring adherence by frequent viral load assay is not always feasible or sustainable in rural communities. A relatively cheaper, reliable, valid and sustainable measure of adherence for children is required for routine management. This study retrospectively assessed adherence outcomes using monthly pill count and viral load data, including reasons reported for non-adherence, in a paediatric cohort in rural KwaZulu-Natal, South Africa. Between 2008 and 2013, 78 children, mean age of 7.1 years, were enrolled in the CAPRISA 052 AIDS Treatment Programme. Monthly treatment adherence by pill count was categorized as either high (≥95 %) or low (<95 %). Overall median monthly adherence to treatment by pill count was 87.8 % at month 6, 88.9 % at month 12 and 90.8 % at month 24. However, the proportion of children with an undetectable viral load (<400 copies/ml) was 84.0 % (63/74), 86.6 % (58/67), and 84.5 % (49/58) at the three time points respectively. Agreement between pill count and viral load showed that only 33.9, 36. 3 and 30.6 % of children were truly adherent by pill count at months 6, 12 and 24 respectively. In conclusion, this treatment programme demonstrated that adherence of >95 % by pill count is not an ideal indicator of virological suppression in children aged 6 months to 13 years. Viral load assessment remains the gold standard for assessing treatment success in this age group.

Indexed as

Drug MonitoringPatient ComplianceRural PopulationAdolescentAnti-HIV AgentsCD4 Lymphocyte CountChildChild, PreschoolCohort StudiesFemaleHIV InfectionsHumansMaleReproducibility of ResultsRetrospective StudiesSouth AfricaAnti-HIV AgentsAdherenceARVsChildrenPaediatricRural

Identifiers

PMID27289369
PMCPMC5071125

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.